Plain-English translation of NCT07332481 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This is a large international study testing whether a new medication called can help improve the skin symptoms of lupus. Participants will either receive the medication or a placebo (a pill with no active ingredient) for 24 weeks while continuing their regular lupus care. Researchers want to see if this treatment is safe and effective for people with lupus-related skin disease.
Lupus skin disease can be painful, disfiguring, and difficult to treat with current options. This medication is being studied to see if it offers patients a new, potentially more effective way to control their skin symptoms.
You likely qualify if…
You likely don't qualify if…
You will visit the study clinic every 4 weeks for 24 weeks, plus one brief video visit at week 2. During these visits, your doctors will check your skin symptoms, take blood tests, and ask how you are feeling. You will take either the new medication or a placebo as a tablet by mouth. After the 24-week treatment period ends, there will be additional follow-up visits to monitor your health.
AI-generated summary from trial data · Aug 2, 2026 · Not medical advice
United States